Developments in Diagnosis and Antileishmanial Drugs
Leishmaniasis ranks the third in disease burden in disability-adjusted life years caused by neglected tropical diseases and is the second cause of parasite-related deaths after malaria; but for a variety of reasons, it is not receiving the attention that would be justified seeing its importance. Lei...
Saved in:
Main Authors: | Prachi Bhargava, Rajni Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Interdisciplinary Perspectives on Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2012/626838 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies to Overcome Antileishmanial Drugs Unresponsiveness
by: Shyam Sundar, et al.
Published: (2014-01-01) -
2-Aminothiophene Derivatives—New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
by: Rodrigo Santos Aquino de Araújo, et al.
Published: (2025-01-01) -
Synthesis and Antileishmanial Activity of Lipophilic Aromatic Aminoalcohols
by: Roberta Novaes Reis Corrales, et al.
Published: (2010-01-01) -
Antileishmanial Activity of Aldonamides and N-Acyl-Diamine Derivatives
by: Elaine S. Coimbra, et al.
Published: (2008-01-01) -
Screening of six medicinal plant species for antileishmanial activity
by: Ferreira Fabiana Borges Padilha, et al.
Published: (2021-09-01)